CR7764A - Nuevo procedimiento de sintesis industrial del ranelato de estroncio y sus hidratos - Google Patents

Nuevo procedimiento de sintesis industrial del ranelato de estroncio y sus hidratos

Info

Publication number
CR7764A
CR7764A CR7764A CR7764A CR7764A CR 7764 A CR7764 A CR 7764A CR 7764 A CR7764 A CR 7764A CR 7764 A CR7764 A CR 7764A CR 7764 A CR7764 A CR 7764A
Authority
CR
Costa Rica
Prior art keywords
hydrates
industrial synthesis
strontium ranelate
synthesis procedure
new industrial
Prior art date
Application number
CR7764A
Other languages
English (en)
Inventor
Lucille Vaysse-Ludot
Jean Pierre Lecouve
Pascal Langlois
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of CR7764A publication Critical patent/CR7764A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Inorganic Insulating Materials (AREA)

Abstract

Se refiere a un procedimiento de sintesis industrial de ranelato de estroncio de formula (I) o sal distronica del acido 5-[bis(carboximetil)amino]-3-carboximetil-4-ciano-2-tiafenocarboxilico y sus hidratos.
CR7764A 2002-09-24 2005-03-18 Nuevo procedimiento de sintesis industrial del ranelato de estroncio y sus hidratos CR7764A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0211763A FR2844795B1 (fr) 2002-09-24 2002-09-24 Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates

Publications (1)

Publication Number Publication Date
CR7764A true CR7764A (es) 2005-10-06

Family

ID=29415189

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7764A CR7764A (es) 2002-09-24 2005-03-18 Nuevo procedimiento de sintesis industrial del ranelato de estroncio y sus hidratos

Country Status (38)

Country Link
US (1) US7214805B2 (es)
EP (1) EP1403266B1 (es)
JP (1) JP4136867B2 (es)
KR (1) KR100551501B1 (es)
CN (1) CN1212321C (es)
AP (1) AP1910A (es)
AR (1) AR041355A1 (es)
AU (2) AU2003248281B2 (es)
BR (1) BR0304213A (es)
CA (1) CA2442878C (es)
CR (1) CR7764A (es)
CY (1) CY1115162T1 (es)
DK (1) DK1403266T3 (es)
EA (1) EA007489B1 (es)
EC (1) ECSP055741A (es)
ES (1) ES2478620T3 (es)
FR (1) FR2844795B1 (es)
GE (1) GEP20074215B (es)
HK (1) HK1065791A1 (es)
HR (1) HRP20050359B1 (es)
IL (1) IL167316A (es)
IS (1) IS7807A (es)
MA (1) MA26102A1 (es)
ME (1) ME00455B (es)
MX (1) MXPA03008643A (es)
MY (1) MY134921A (es)
NO (1) NO328638B1 (es)
NZ (1) NZ528402A (es)
OA (1) OA12934A (es)
PL (1) PL214400B1 (es)
PT (1) PT1403266E (es)
RS (2) RS20050240A (es)
SG (1) SG110071A1 (es)
SI (1) SI1403266T1 (es)
TN (1) TNSN05087A1 (es)
UA (1) UA79156C2 (es)
WO (1) WO2004029036A1 (es)
ZA (1) ZA200307409B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2266584T3 (da) * 2003-05-07 2013-01-02 Osteologix As Sammensætning med strontium og D-vitamin til profylakse og/eller behandling af brusk- og knogletilstande
DE602004002832T2 (de) * 2003-05-07 2007-06-06 Osteologix A/S Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen
AU2005216596B2 (en) 2004-02-26 2011-03-24 Osteologix A/S Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
EP1744770A2 (en) 2004-05-06 2007-01-24 Osteologix A/S High yield and rapid syntheses methods for producing metallo-organic salts
EP1768748B2 (en) 2004-06-25 2019-03-13 Mokwalo Pharma S.A. Compositions comprising strontium and vitamin d and uses thereof
FR2875807B1 (fr) * 2004-09-30 2006-11-17 Servier Lab Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CN100538672C (zh) * 2005-04-18 2009-09-09 索尼株式会社 控制设备和方法
CN100391955C (zh) * 2005-04-30 2008-06-04 河北医科大学 一种雷尼酸锶中间体的合成方法
AU2006281157B2 (en) * 2005-08-19 2013-03-28 Glenmark Pharmaceuticals Limited Process for the preparation of strontium ranelate
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
FR2921367B1 (fr) * 2007-09-26 2009-10-30 Servier Lab Nouveau procede de synthese du ranelate de strontium et de ses hydrates
US20120123131A1 (en) * 2008-08-22 2012-05-17 Koilpillai Joseph Prabahar Process for the preparation of strontium ranelate
HU228820B1 (en) 2010-01-14 2013-05-28 Richter Gedeon Nyrt Process for the preparation of distrontium ranelate
WO2011110597A1 (de) 2010-03-11 2011-09-15 Azad Pharmaceutical Ingredients Ag Verfahren zur herstellung von strontiumranelat
WO2011124992A1 (en) * 2010-03-24 2011-10-13 Actavis Group Ptc Ehf Substantially pure strontium ranelate
WO2013013003A1 (en) 2011-07-21 2013-01-24 Emory University Methods for treating inflamatory conditions and states, and cancers by antagonizing nf-kb activation
CN102321068B (zh) * 2011-08-01 2013-01-23 山东铂源药业有限公司 一种雷奈酸锶的制备方法
WO2013175270A1 (en) * 2012-05-25 2013-11-28 Fleming Laboratories Limited Improved process for the preparation of strontium ranelate hydrates and new polymorphic form of monohydrate
ES2505716T3 (es) 2013-01-21 2015-09-04 Galenicum Health S.L. Composiciones farmacéuticas que comprenden una sal de ácido
CN103319454B (zh) * 2013-06-14 2014-06-18 广东众生药业股份有限公司 一种高纯度雷尼酸四乙酯及其中间体的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651497B1 (fr) * 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
FR2844797B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844796A1 (fr) * 2002-09-24 2004-03-26 Servier Lab Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates

Also Published As

Publication number Publication date
AU2003248281B2 (en) 2009-08-06
ECSP055741A (es) 2005-07-06
CA2442878C (fr) 2009-03-03
CN1212321C (zh) 2005-07-27
NZ528402A (en) 2004-07-30
PL362365A1 (en) 2004-04-05
MXPA03008643A (es) 2005-04-19
OA12934A (en) 2006-10-13
TNSN05087A1 (fr) 2007-05-14
JP2004149516A (ja) 2004-05-27
DK1403266T3 (da) 2014-07-07
PT1403266E (pt) 2014-05-06
SI1403266T1 (sl) 2014-06-30
ME00455B (me) 2011-10-10
WO2004029036A1 (fr) 2004-04-08
IL167316A (en) 2008-08-07
AR041355A1 (es) 2005-05-11
EP1403266A1 (fr) 2004-03-31
RS20050240A (en) 2007-06-04
FR2844795A1 (fr) 2004-03-26
CA2442878A1 (fr) 2004-03-24
EA200300925A1 (ru) 2004-04-29
SG110071A1 (en) 2005-04-28
BR0304213A (pt) 2004-08-31
AP1910A (en) 2008-10-30
NO328638B1 (no) 2010-04-12
PL214400B1 (pl) 2013-07-31
NO20034235L (no) 2004-03-25
KR20040026625A (ko) 2004-03-31
MY134921A (en) 2008-01-31
CY1115162T1 (el) 2016-12-14
ES2478620T3 (es) 2014-07-22
MA26102A1 (fr) 2004-04-01
HK1065791A1 (en) 2005-03-04
US7214805B2 (en) 2007-05-08
CN1496986A (zh) 2004-05-19
EP1403266B1 (fr) 2014-04-09
FR2844795B1 (fr) 2004-10-22
ZA200307409B (en) 2004-07-07
UA79156C2 (en) 2007-05-25
IS7807A (is) 2005-04-19
HRP20050359B1 (hr) 2014-09-26
RS53509B1 (en) 2015-02-27
JP4136867B2 (ja) 2008-08-20
AU2003282179A1 (en) 2004-04-19
GEP20074215B (en) 2007-10-10
HRP20050359A2 (en) 2005-06-30
KR100551501B1 (ko) 2006-02-13
AU2003248281A1 (en) 2004-04-08
US20040063972A1 (en) 2004-04-01
NO20034235D0 (no) 2003-09-23
AP2005003256A0 (en) 2005-03-31
EA007489B1 (ru) 2006-10-27

Similar Documents

Publication Publication Date Title
CR7764A (es) Nuevo procedimiento de sintesis industrial del ranelato de estroncio y sus hidratos
HN2008001490A (es) Nuevo procedimiento de sintesis del ranelato de estroncio y de sus hidratos
ECSP055742A (es) Nuevo método para la síntesis industrial de diéster de metilo del ácido 5-amino-3-carboximetil-4-ciano-2-tiofencarboxílico y aplicación para la síntesis de sales bivalentes de ácido ranélico y sus hidratos
ECSP055743A (es) Nuevo proceso para la sintesis industrial de tetraésteres del acido 5-[bis(carboximetil)amino]-3-carboximetil-4-ciano-2- tiofeno carboxílico y aplicación para la síntesis de sales bivalentes de acido ranelico y sus hidratos
CO5611131A2 (es) Derivados de 5-feniltiazol y su uso como inhibidores de pi3 cinasa
TW200736221A (en) Novel pharmaceutical salts and polymorphs of a Factor Xa inhibitor
TN2010000219A1 (en) 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
EA200600878A1 (ru) Производные феноксиуксусных кислот, применимые в качестве двойных агонистов активируемого пероксисомным пролифератором рецептора ( ppar )
HK1107984A1 (en) Pyrrolopyridine-2-carboxylic acid amide derivativeuseful as inhibitor of glycogen phosphorylase
GB0215392D0 (en) Chemical compounds
CU23386A3 (es) Nuevo metodo para la sintesis industrial de ranelato de estroncio y los hidratos del mismo
TW200745071A (en) Process for making substituted piperazinyl compounds
UA99279C2 (ru) Замещенные сульфонамиды, способ их получения, фармацевтическая композиция, которая их содержит, и их применение
UA94261C2 (ru) Фармацевтическая композиция для внешнего применения
TNSN08355A1 (fr) Nouveau procede de synthese du ranelae de strontium et de ses hydrates
CU20090211A7 (es) Nuevo procedimiento de síntesis industrial del diester metílico del ácido 5-amino-3-carboximetil-4-ciano-2-tiofeno carboxílico, y aplicaciones a la síntesis de las sales bivalentes del ácido ranélico y de sus hidratos